CG Oncology (CGON) shares outstanding

Shares outstanding · fiscal 2025
77.30M

CG Oncology (CGON) had 77.30M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 23.7% higher than the 62.50M of fiscal 2024. Figures as of 18 Nov 2026, 12:14 UTC, from Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
77.30M
Change on fiscal 2024
+23.7%
Highest on record
77.30Mfiscal 2025
Lowest on record
3.74Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

CG Oncology shares outstanding, in more detail

The market data feed counts 89.32M shares outstanding today.

Across the 4 fiscal years on record (2022–2025), the highest was 77.30M in fiscal 2025 and the lowest 3.74M in fiscal 2022.

History · 4 fiscal years

Shares outstanding by fiscal year

CG Oncology shares outstanding, year by year

CG Oncology (CGON) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202577.30M 23.7% up
202462.50M 1,343.0% up
20234.33M 15.8% up
20223.74M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of CG Oncology and comparable companies
CompanyShares outstandingFiscal year
Oruka Therapeutics ORKA45.61M2025
Arrowhead Pharmaceuticals ARWR141.29M2026
MSA Safety MSA39.35M2025
CG Oncology CGON77.30M2025
Kodiak Sciences KOD53.21M2025
Lantheus Holdings LNTH68.44M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on CGON

CG Oncology, figure by figure

CG Oncology (CGON) overview: price, valuation and scorecardAll health care companies by market value

CG Oncology shares outstanding: questions and answers

How many shares does CG Oncology have?

CG Oncology (CGON) had 77.30M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 23.7% higher than the 62.50M of fiscal 2024. The market data feed counts 89.32M shares outstanding today.

What are the highest and lowest diluted share count figures on record for CG Oncology?

Across the 4 fiscal years on record (2022–2025), the highest was 77.30M in fiscal 2025 and the lowest 3.74M in fiscal 2022.

How is CG Oncology's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For CG Oncology it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “CG Oncology (CGON) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/CGON/shares-outstanding

Underlying data: Yahoo Finance.